| Amazon Title | Mucinex 12 hour Chest Congestion Medicine, Chest Congestion Relief, Expectorant, Lasts 12 hours, Powerful Symptom Relief, Extended-Release Bi-layer tablets, 20+4 count (Bonus 4 Free Tablets) |
|---|
| Bullet Features | - MUCINEX CHEST CONGESTION MEDICINE: Clinically proven to last up to 12 hours and provide relief for your chest congestion and make cough more productive
- POWERFUL SYMPTOM RELIEF: Mucinex 12 hour relieves chest congestion and thins and loosens mucus
- BI-LAYER TABLET: A unique bi-layer tablet, one layer for immediate release and one layer for extended release so the medicine starts to release right away and last for up to 12 hours
- #1 TRUSTED COLD & COUGH BRAND: Mucinex is the #1 Cold and Cough brand doctors trust* and #1 Pharmacist Recommended Brand†
- CONTINUOUS RELIEF: Mucinex lasts up to 12 hours so you can say goodbye to retaking medicine every 4 hours
- ACTIVE INGREDIENT: Contains Guaifenesin which is an expectorant that relieves chest congestion and thins & loosens mucus making cough more productive
- USAGE: Use as directed; Adults and Children 12 years of age and over
|
|---|
| Product Description | Mucinex Extended-release Bi-layer tablets provide powerful symptom relief. The product relieves chest congestion, thins and loosens mucus and lasts for 12 hours. It contains a unique bi-layer tablet - one layer for immediate release and one layer for extended release, so the medicine starts to release right away and lasts for up to 12 hours, so you can say goodbye to retaking medicine every 4 hours. Mucinex is the #1 Cough & Cold Brand Doctors Trust* and the #1 Pharmacist Recommended Brand† as well. This product contains 120 tablets. It can be used by Adults and Children 12 years of age and over.
KEY SYMPTOMS RELIEVED: Mucinex Extended-release Bi-layer tablets relieve chest congestion and thin and loosen mucus
ACTIVE INGREDIENT: Contains Guaifenesin which is an expectorant that relieves chest congestion and thins & loosens mucus making cough more productive
Use as directed
*IQVIA using ProVoice Survey, December 2021
†U.S. News & World Report/Pharmacy Times 2022-2023 |
|---|
